FAQ: Information for health professionals on apheresis platelet psoralen-treated (APPT) and untreated apheresis platelet in PAS-E

The importance of iron for whole blood donors: a Canadian perspective

FAQ: Solvent detergent (S/D) treated plasma (Octaplasma)

FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services

Summary of adverse transfusion reactions 2017-2022

FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services

FAQ: Information for health professionals on pathogen-reduced platelets (PPPT)

Surveillance report

FAQ: Canadian Blood Services platelet bacterial screening

Transfusion-related acute lung injury (TRALI)

Anaphylactic transfusion reactions and IgA deficiency

Impact of COVID-19 on blood donation in Canada

Exploring the frontiers of IVIG-associated hemolysis

Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice

A Guide to Reporting Adverse Transfusion Reactions

Striking the balance: protecting data privacy in research

Platelet product quality remains high after seven days of storage

Paying it forward: Why we need YOU to give blood

Alternative methods of blood donor skin disinfection

Blood: the basics

Molecular immunohematology at Canadian Blood Services: Red cell antigen genotyping

Emergency framework for rationing of blood for massively bleeding patients during a red phase blood shortage

A survey of Canadian MLTs’ views on continuing education in transfusion science

National plan for the management of shortages of labile blood components

Blood bag spiking procedure